Drreddys Laboratories reported INR14.18B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
ANI Pharmaceuticals USD 8.14M 7.54M Jun/2025
Aurora Cannabis CAD -15210000 46.88M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Canopy Growth CAD -41530000 80.37M Jun/2025
Cipla INR 12.98B 757.8M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Drreddys Laboratories INR 14.18B 45M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Lonza CHF 307M 22M Dec/2024
Novartis USD 4.02B 418M Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Prestige Brands USD 61.78M 11.65M Jun/2025
Richter Gedeon HUF 37.06B 32.94B Sep/2024
Sun Pharmaceuticals INR 22.79B 1.29B Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025